NESTLEIND vs SUNPHARMA: Stock Comparison
SUN PHARMACEUTICAL IND L is the larger company by market capitalisation. NESTLE INDIA shows a higher ROE, a higher dividend yield and faster revenue growth, while SUN PHARMACEUTICAL IND L shows a lower P/E and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
NESTLEIND leads 6; SUNPHARMA leads 7 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | NESTLEIND | SUNPHARMA |
|---|---|---|
| Sector | Fast Moving Consumer Goods | Healthcare |
| Industry | Packaged Foods | Pharmaceuticals |
Price
| Metric | NESTLEIND | SUNPHARMA |
|---|---|---|
| Live Price | ₹1,341.4 | ₹1,804.1 |
| Day Change | 3.42% | 1.37% |
| Volume | 16.51 L | 14.78 L |
| 52-Week High | ₹1,553 | ₹2,046.9 |
| 52-Week Low | ₹1,158.6 | ₹1,583.7 |
| Distance from 52W High | -13.63% | -11.86% |
Valuation
| Metric | NESTLEIND | SUNPHARMA |
|---|---|---|
| Market Cap | ₹2.58 L Cr | ₹4.32 L Cr |
| P/E Ratio | 67.58x | 35.73x |
| P/B Ratio | 49.94x | 5.17x |
| EPS | ₹19.77 | ₹49.8 |
| Book Value | ₹26.74 | ₹348.31 |
| Dividend Yield | 0.92% | 0.89% |
Growth
| Metric | NESTLEIND | SUNPHARMA |
|---|---|---|
| Revenue Growth (TTM YoY) | 23% | 12.8% |
| EPS Growth (TTM YoY) | 27.4% | 25.6% |
| Qtr Sales Growth | 0% | 166.5% |
| Qtr Profit Growth | -1.69% | 160.17% |
Profitability & Leverage
| Metric | NESTLEIND | SUNPHARMA |
|---|---|---|
| ROE | 66.76% | 13.72% |
| ROCE | 91.36% | 15.12% |
| Net Margin | 15.14% | 18.56% |
| Operating Margin | 20.59% | 26.44% |
| Debt to Equity | 0x | 0.05x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | NESTLEIND | SUNPHARMA |
|---|---|---|
| Promoter Holding | 62.76% | 54.48% |
| FII Holding | 10.29%▲ 0.55 pp | 14.53%▼ 1.4 pp |
| DII Holding | 11.9%▼ 0.49 pp | 22.18%▲ 1.07 pp |
| Public Holding | 15.04%▼ 0.06 pp | 8.81%▲ 0.33 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: NESTLE INDIA and SUN PHARMACEUTICAL IND L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.